- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 1, 2025 | 4.25M sh |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $6.22M |
| Short Term Investments | Q2 2025 · Jun 30, 2024 | $6.5M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $10.32M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $10.04M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $31.84M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $31.33M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $6.75M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $9.42M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $7.57M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $10.96M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $30.65M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $32.18M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $42.54M |
| Total Assets | Q2 2025 · Dec 31, 2023 | $46.6M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 4.26M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 4.27M sh |
| Capex | Q2 2025 · Dec 31, 2023 | $158K |
| Operating Cash Flow restated | Q2 2025 · Dec 31, 2023 | $1.37M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.12 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.17 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.12 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.18 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $1.82M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $3.98M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $131K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $216K |
| Net Income | Q2 2025 · Dec 31, 2023 | $507K |
| Net Income | Q2 2025 · Dec 31, 2023 | $737K |
| Operating Income | Q2 2025 · Dec 31, 2023 | $677K |
| Operating Income | Q2 2025 · Dec 31, 2023 | $676K |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $2.85M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $5.37M |